Roivant Sciences (ROIV) FCF Margin (2020 - 2025)
Roivant Sciences (ROIV) reported FCF Margin of 29688.79% for Q4 2025, down 2225174.0% on a YoY basis from N/an in Q4 2024, and down 141.02% quarter-over-quarter from 12317.76% in Q3 2025.
Roivant Sciences (ROIV) FCF Margin (2020 - 2025) Analysis & Trends
Roivant Sciences has reported FCF Margin for 6 years, with the latest figure at 29688.79% in Q4 2025.
- For the quarter ending Q4 2025, FCF Margin fell 2225174.0% year-over-year to 29688.79%; the trailing twelve-month figure through Dec 2025 stood at 6744.88% (down 368841.0% YoY), and the FY2026 full-year result was 9183.51%, down 627830.0% from the prior year.
- FCF Margin for Q4 2025 stood at 29688.79%, down from 12317.76% in the prior quarter.
- The five-year high for FCF Margin was 881.94% in Q3 2021, with the low at 29688.79% in Q4 2025.
- Historically, FCF Margin has averaged 6313.62% across 5 years, with a median of 4227.25% in 2023.
- Annual changes were most pronounced in 2021 — FCF Margin jumped 521784 bps — and 2025, when it tumbled 2225174 bps.
- Roivant Sciences' FCF Margin stood at 2224.37% in 2021, then slumped by 78 bps to 3960.67% in 2022, then retreated by 7 bps to 4227.25% in 2023, then tumbled by 76 bps to 7437.06% in 2024, then sank by 299 bps to 29688.79% in 2025.
- The last three FCF Margin figures came in at 29688.79% (Q4 2025), 12317.76% (Q3 2025), and 9604.52% (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -3.98% |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 43.35% |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Roivant Sciences | 21.82 Bn | 22.59 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -29,688.79% |
| Sep 30, 2025 | -12,317.76% |
| Jun 30, 2025 | -9,604.52% |
| Dec 31, 2024 | -7,437.06% |
| Sep 30, 2024 | -5,984.40% |
| Jun 30, 2024 | -2,425.46% |
| Dec 31, 2023 | -4,227.25% |
| Sep 30, 2023 | -5,392.05% |
| Jun 30, 2023 | -1,157.67% |
| Dec 31, 2022 | -3,960.67% |
| Sep 30, 2022 | -1,537.79% |
| Jun 30, 2022 | -6,009.28% |
| Dec 31, 2021 | -2,224.37% |
| Sep 30, 2021 | -881.94% |
| Jun 30, 2021 | -1,855.32% |
| Dec 31, 2020 | -3,146.45% |
| Jun 30, 2020 | -7,073.16% |